ETPharma says Cipla aims to be in the first wave of Keytruda biosimilars and is seeing Yurpeak sales rise about 5% a month.
Recap by typeshit. Post by ETPharma on X.
Beauty companies are reportedly exploring products aimed at facial volume loss in people who have lost weight on GLP-1 drugs.
A short Fox16 social clip points to GLP-1 users shifting how they drink when they go out, with the full story linked in the station's bio.
A Facebook share points to shifting drinking habits in pubs and bars as more people take GLP-1 medications, with the full story linked.
Food Dive reports the Atkins brand is shifting its pitch toward lapsed GLP-1 users, a growing group food companies are now chasing.
Employers on the Andel marketplace set their own contribution toward Wegovy, the daily Wegovy pill and Wegovy HD, with manufacturer-direct pricing and no insurance involved.
Highlights include a real-world comparison of Wegovy 2.4 mg against resmetirom in MASH and ESSENCE data in people with a BMI under 27, presented Nov. 5 to 9 in Denver.
Loading…